SCHEMBL21085252

SCHEMBL21085252

CC(C)[C@@H](C)N1CCc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
TSHR P16473 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
SLC6A2 P23975 2/20 0.46
SLC6A4 P31645 2/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
CDK4 P11802 1/20 0.46
ALOX15 P16050 1/20 0.46
CCND1 P24385 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 3/20 0.45
NOTUM Q6P988 1/20 0.44
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
GAA P10253 2/20 0.44
GFER P55789 1/20 0.44
DRD2 P14416 1/20 0.44
DRD1 P21728 1/20 0.44
DRD4 P21917 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21095412 0.89 NPSR1 (0.49) ALDH1A1TSHRNPSR1MEN1KMT2A
SCHEMBL1102007 0.84 ALDH1A1 (0.48) ALDH1A1TSHRNPSR1SLC6A2SLC6A4
SCHEMBL6262183 0.81 SLC6A2 (0.52) ALDH1A1TSHRNPSR1SLC6A2SLC6A4
SCHEMBL11852260 0.81 GAA (0.47) ALDH1A1TSHRNPSR1SLC6A2SLC6A4
SCHEMBL16600454 0.81 ALDH1A1 (0.46) ALDH1A1TSHRNPSR1SLC6A2SLC6A4
SCHEMBL14060360 0.81 ALDH1A1 (0.46) ALDH1A1TSHRNPSR1SLC6A2SLC6A4
SCHEMBL20957018 0.80 SLC6A2 (0.46) ALDH1A1TSHRNPSR1SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL31467512 0.79 SLC6A2 (0.47) ALDH1A1TSHRNPSR1SLC6A2SLC6A4
SCHEMBL24729037 0.78 ALDH1A1 (0.47) ALDH1A1TSHRNPSR1SLC6A2SLC6A4
SCHEMBL8216960 0.78 ALDH1A1 (0.47) ALDH1A1TSHRNPSR1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190167651-A1 HETEROARYL SULFONAMIDES AND CCR2/CCR9 CHEMOCENTRYX, INC. 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190167651-A1 HETEROARYL SULFONAMIDES AND CCR2/CCR9 CCR2, CCR9, CCR1 ALDH1A1 2834/4885TSHR 1094/4885NPSR1 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.